Skip to main navigation Skip to search Skip to main content

Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide

M Horowitz, Tina Vilsbøll, M Zdravkovic, M Hammer, S Madsbad

26 Citations (Scopus)
Original languageEnglish
JournalDiabetes, Obesity and Metabolism
Volume10
Issue number7
Pages (from-to)593-6
Number of pages4
ISSN1462-8902
DOIs
Publication statusPublished - 1 Jul 2008

Cite this